The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives

Eyre, TA; Riches, JC

Riches, JC (通讯作者)，Queen Mary Univ London, Barts Canc Inst, Ctr Haemato Oncol, London EC1M 6BQ, England.

CANCERS, 2023; 15 (9):

Abstract

The development of inhibitors of Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (BCL2) has resulted in a paradigm shift in the treatment of chroni......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索